Presumably, expansion of CD38- B cells with Foxp3+ and/or IL-10 expression counteracts reduced numbers of CD38+Foxp3+IL-10+ Bregs and is a sign of a compensatory mechanism aimed at the reduction in autoimmune reactions related to Graves’ disease. The gene discussed is CD38; the disease is Graves disease.